Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of epstein-barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 382-394

  Cao, Jennifer Yinuo ^a   Mansouri, Sheila ^a   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; EPSTEIN BARR VIRUS ANTIGEN 1; MASPIN; NUCLEAR PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 1; PROTEOME; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STATHMIN; STATHMIN 1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; MASS SPECTROMETRY; METASTASIS; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; TRANSCRIPTION INITIATION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL NUCLEUS; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; OXIDATIVE STRESS; PROTEOME; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

HUMAN HERPESVIRUS 4;

EID: 84855935664     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05648-11     Document Type: Article

References (57)

1. Alfonso P, Rivera J, Hernaez B, Alonso C, Escribano JM. 2004. Identification of cellular proteins modified in response to African swine fever virus infection by proteomics. Proteomics 4:2037-2046.
2. Antrobus R, et al. 2009. Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics 9:3913-3927.
3. Babcock GJ, Hochberg D, Thorley-Lawson AD. 2000. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13:497-506.
4. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. 2006. Biological functions of maspin. J. Cell. Physiol. 209:617-624.
5. Belfiore MC, et al. 2007. Involvement of 5-lipoxygenase in survival of Epstein-Barr virus (EBV)-converted B lymphoma cells. Cancer Lett. 254: 236-243.
6. Belletti B, et al. 2008. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol. Biol. Cell 19:2003-2013.
7. Brasier AR, et al. 2004. Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J. Virol. 78:11461-11476.
8. Canaan A, et al. 2009. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc. Natl. Acad. Sci. U. S. A. 106:22421-22426.
9. Casado-Vela J, Selles S, Martinez RB. 2006. Proteomic analysis of tobacco mosaic virus-infected tomato (Lycopersicon esculentum M.) fruits and detection of viral coat protein. Proteomics 6(Suppl 1):S196 -S206.
10. Cerimele F, et al. 2005. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc. Natl. Acad. Sci. U. S. A. 102:175-179.
11. Chen SJ, et al. 2010. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 5:e12745.
12. Cheung ST, et al. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83:121-126.
13. Cosmopoulos K, et al. 2009. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 83:2357-2367.
14. Dallaire F, Blanchette P, Branton PE. 2009. A proteomic approach to identify candidate substrates of human adenovirus E4orf6-E1B55K and other viral cullin-based E3 ubiquitin ligases. J. Virol. 83:12172-12184.
15. Eruslanov E, Kusmartsev S. 2010. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 594:57-72.
16. Fang L, et al. 2010. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549. Cell Signal. 22:166-173.
17. Frappier L. 2010. EBNA1 in viral replication and persistence. Caister Academic Press, Norwich, United Kingdom.
18. Garbi N, Tan P, Momburg F, Hammerling GJ. 2001. Role of tapasin in MHCclass I antigen presentation in vivo. Adv. Exp. Med. Biol. 495:71-78.
19. Gargouri B, et al. 2009. High levels of autoantibodies against catalase and superoxide dismutase in nasopharyngeal carcinoma. South. Med. J. 102: 1222-1226.
20. Gruhne B, et al. 2009. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 106:2313-2318.
21. Hansen TH, Bouvier M. 2009.MHCclass I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9:503-513.
22. Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L. 2003. Protein interaction domains of the ubiquitin-specific protease, USP7/ HAUSP. J. Biol. Chem. 278:47753- 47761.
23. Holowaty MN, et al. 2003. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278: 29987-29994.
24. Hong M, et al. 2006. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. J. Cancer Res. Clin. Oncol. 132:1-8.
25. Iancu-Rubin C, Atweh GF. 2005. p27(Kip1) and stathmin share the stage for the first time. Trends Cell Biol. 15:346 -348.
26. Inoue E, et al. 2010. SOD1 is essential for the viability of DT40 cells and nuclear SOD1 functions as a guardian of genomic DNA. J. Nucleic Acids 2010:795946.
27. Kaul R, Murakami M, Choudhuri T, Robertson ES. 2007. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J. Virol. 81:10352-10361.
28. Kennedy G, Komano J, Sugden B. 2003. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. U. S. A. 100:14269 -14274.
29. Khalkhali-Ellis Z. 2006. Maspin: the new frontier. Clin. Cancer Res. 12: 7279-7283.
30. Lassoued S, et al. 2008. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol. Cell. Biochem. 313:179-186.
31. Li M, et al. 2002. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416:648-653.
32. Lin W-J, et al. 2011. Posttranscriptional control of type I interferon genes by KSRP in the innate immune response against viral infection. Mol. Cell. Biol. 31:3196 -3207.
33. Lin X, et al. 2009. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells. Int. J. Cancer 124:1020 -1027.
34. Lu J, et al. 2011. Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through upregulation of survivin. Virology 410:64-75.
35. Miao L, St Clair DK. 2009. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med. 47:344 -356.
36. Murakami M, Lan K, Subramanian C, Robertson ES. 2005. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J. Virol. 79: 1559-1568.
37. Ogino T, et al. 2007. Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma. Int. J. Cancer 120:2401-2410.
38. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
39. Rana S, Maples PB, Senzer N, Nemunaitis J. 2008. Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev. Anticancer Ther. 8:1461-1470.
40. Rickinson AB, Kieff KE. 2001. Epstein-Barr virus, p. 2575-2627. In Knipe DM, et al (ed), Fields virology, 2nd ed,vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
41. Saridakis V, et al. 2005. Structure of the p53 binding domain of HAUSP/ USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBVmediated immortalization. Mol. Cell 18:25-36.
42. Schlee M, et al. 2004. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV. J. Virol. 78:3941-3952.
43. Sheng S, et al. 1996. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. U. S. A. 93:11669-11674.
44. Sheng Y, et al. 2006. Molecular recognition of p53 and MDM2 by USP7/ HAUSP. Nat. Struct. Mol. Biol. 13:285-291.
45. Sheu LF, et al. 1996. Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J. Pathol. 180:243-248.
46. Sivachandran N, Cao JY, Frappier L. 2010. Epstein-Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 84:11113-11123.
47. Sivachandran N, Sarkari F, Frappier L. 2008. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 4:e1000170.
48. Sompallae R, Callegari S, Kamranvar SA, Masucci MG. 2010. Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes. PLoS One 5:e12052.
49. Sun Y, et al. 1992. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 89: 6516-6520.
50. Terashima M, et al. 2005. Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br. J. Cancer 92:1130 -1136.
51. Trabucchi M, et al. 2009. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459:1010 -1014.
52. Valko M, et al. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39:44-84.
53. Ventelon-Debout M, et al. 2004. Proteome analysis of cultivar-specific deregulations of Oryza sativa indica and O. sativa japonica cellular suspensions undergoing rice yellow mottle virus infection. Proteomics 4:216 -225.
54. Wood VH, et al. 2007. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 26:4135- 4147.
55. Yin Q, Flemington EK. 2006. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBVdependent tumor cells. Virology 346:385-393.
56. Zeghouf M, et al. 2004. Sequential peptide affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J. Proteome Res. 3:463- 468.
57. Zhu JY, et al. 2009. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J. Virol. 83:3333-3341. sadam4